US Patent 7671035 Epidermal growth factor receptor antisense oligonucleotides
Patent 7671035 was granted and assigned to Idera Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+145 characters)
Article
Patent abstract
Disclosed are synthetic oligonucleotides complementary to nucleic acids encoding epidermal growth factor and methods of their use.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07671035 Epidermal growth factor receptor antisense oligonucleotides US Patent 7671035 Epidermal growth factor receptor antisense oligonucleotides
Infobox
Patent Number
0767103500
Patent Number
767103500
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076710350
Date of Patent
March 2, 2010
0Patent Application Number
101402280
Date Filed
May 7, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076710350
Date of Patent
March 2, 2010
0Patent Application Number
101402280
Date Filed
May 7, 2002
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07671035 Epidermal growth factor receptor antisense oligonucleotides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07671035
Date of patent
March 2, 2010
Patent application number
10140228
Date Filed
May 7, 2002
Patent primary examiner
Find more entities like US Patent 7671035 Epidermal growth factor receptor antisense oligonucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.